Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Next Science Ltd ( (AU:NXS) ) just unveiled an update.
Next Science Limited has confirmed payment of its previously announced cash return of capital to shareholders, finalising the distribution ahead of its removal from the ASX official list. With the capital return now completed, shareholders with administrative queries have been directed to the company’s share registrar, Automic, for support.
The company has also advised that, having satisfied ASX conditions for voluntary delisting, it has requested removal from the official list effective 11 February 2026. Following delisting, Next Science plans to meet its continuous disclosure obligations by publishing future investor and company updates directly on its website rather than via the ASX platform.
The most recent analyst rating on (AU:NXS) stock is a Hold with a A$0.15 price target. To see the full list of analyst forecasts on Next Science Ltd stock, see the AU:NXS Stock Forecast page.
More about Next Science Ltd
Next Science Limited is an Australian healthcare company listed on the ASX under ticker NXS. The company develops and commercialises medical technologies focused on improving patient healing outcomes and reducing infection risk, targeting clinical settings where advanced wound care and infection management solutions are in demand.
Technical Sentiment Signal: Sell
Current Market Cap: A$42.43M
See more data about NXS stock on TipRanks’ Stock Analysis page.